Milestone Pharmaceuticals Inc. (MIST): Price and Financial Metrics


Milestone Pharmaceuticals Inc. (MIST)

Today's Latest Price: $3.58 USD

0.06 (1.70%)

Updated Jun 4 6:55pm

Add MIST to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MIST Daily Price Range
MIST 52-Week Price Range

MIST Stock Price Chart More Charts


MIST Price/Volume Stats

Current price $3.58 52-week high $27.95
Prev. close $3.52 52-week low $1.69
Day low $3.42 Volume 664,700
Day high $3.64 Avg. volume 1,068,322
50-day MA $2.77 Dividend yield N/A
200-day MA $14.70 Market Cap 88.10M

Milestone Pharmaceuticals Inc. (MIST) Company Bio


Milestone Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. It designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.


MIST Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MIST Latest Social Stream


Loading social stream, please wait...

View Full MIST Social Stream

Latest MIST News From Around the Web

Below are the latest news stories about Milestone Pharmaceuticals Inc that investors may wish to consider to help them evaluate MIST as an investment opportunity.

Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference

Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference

Yahoo | May 27, 2020

Will Milestone Pharmaceuticals Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor of Milestone Pharmaceuticals

Zacks Investment Research | May 20, 2020

Backed by US and foreign investors, Canadian VC sets record at $7.263B for 2019

Backed by US and foreign investors, Canadian VC sets record at $7.263B for 2019

Yahoo | May 20, 2020

Top Ranked Momentum Stocks to Buy for May 19th

Top Ranked Momentum Stocks to Buy for May 19th

Yahoo | May 19, 2020

Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update

Yahoo | May 14, 2020

Read More 'MIST' Stories Here

MIST Price Returns

1-mo 13.29%
3-mo -82.55%
6-mo -78.61%
1-year -81.96%
3-year N/A
5-year N/A
YTD -77.64%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.1918 seconds.